The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 13, 2014

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2017

Conditions

Psoriasis

Interventions

DRUG

etanercept

100 mg Etanercept injections per week (2 separate single-use pre-filled 50 mg subcutaneous injections taken on two separate days) for 3 months

Trial Locations (1)

University of Michigan Department of Dermatology, Ann Arbor